Role of diffusion-weighted imaging and dynamic contrast enhanced magnetic resonance imaging in the diagnosis of early sacroiliitis in seronegative spondyloarthropathies, correlation with levels of acute phase reactants
Objective: Seronegative spondyloarthropathy (SpA) is a destructive disease. Early diagnosis is crucial to prevent morbidity. Magnetic resonance imaging (MRI) is the only imaging modality that can show early sacroiliitis. We aimed to investigate the utility of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) in the detection, quantification and staging of early/acute SpA. We also investigated the relationship between contrast enhancement properties and apparent diffusion coefficient (ADC) values with laboratory parameters for inflammation such as ESR and CRP measurments. Patients and Methods: Dynamic contrast-enhanced magnetic resonance imaging and DWI were performed on 85 patients that fulfilled the criteria. A positive MRI finding was defined as inflammation in subchondral bone representing active sacroiliitis. Kinetic analyses were performed, apparent diffusion coefficient (ADC) values were calculated, ESR and CRP levels were measured for quantification of inflammation. Statistical analyses were performed. Results: In acute SpA group; quantity, area and level of enhancement, values of ADC and Fenh, levels of CRP were significantly higher than those with chronic SpA. A high level of agreement was found between the ADC threshold value of 0.831x10 − 3 mm2/s and diagnosis according to Assessment of SpondyloArthritis International Society (ASAS) criteria (Kappa=0.794;p<0.001). Conclusion: Dynamic contrast-enhanced magnetic resonance imaging and DWI are advanced MR techniques which enable quantification of active inflammation. They are hallmarks for early SpA. Their combined use is superior to one alone in the diagnosis of early sacroiliitis.
___
- [1] Rudwaleit M, Van Der Heijde D, Landewe R, et al. The
Assessment of SpondyloArthritis International Society
Classification Criteria for Peripheral Spondyloarthritis and for
spondyloarthritis ın general. Ann Rheum Dis 2011;70:25-31.
doi: /10.1136/ard.2010.133645
- [2] Mandl P, Navarro-Compán V, Terslev L, et al. EULAR
Recommendations for the use of Imaging in the Diagnosis
and Management of Spondyloarthritis in Clinical
Practice. Ann Rheum Dis 2015;74:1327-39. doi:/10.1136/
annrheumdis-2014-206971
- [3] Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of
SpondyloArthritis International Society (ASAS) handbook:
a guide to assess spondyloarthritis. Ann Rheum Dis
2009;68(Suppl 2):1-44 doi: 10.1136/ard.2008.104018
- [4] Imkamp M, Lima Passos V, Boonen A, et al. Uncovering the
heterogeneity of disease ımpact ın axial spondyloarthritis:
bivariate trajectories of disease activity and quality
of life. RMD Open 2018;14;4:e000755. doi:/10.1136/
rmdopen-2018-000755
- [5] Barkham N, Keen H, Coates L, et al. A randomized controlled
trial of ınfliximab shows clinical and MRI efficacy in patients
with HLA-B27 positive very early ankylosing spondylitis.
Arthritis Rheum 2007;56(Suppl.):L11. doi: 10.1002/art.24408
- [6] Hermann KG, Bollow M. Magnetic resonance ımaging of
sacroiliitis ın patients with spondyloarthritis: correlation
with anatomy and histology. Rofo 2014;186:230-7.
doi:10.1055/s-0033.135.0411
- [7] Jevtic V, Kos-Golja M, Rozman B, McCall I. Marginal erosive
discovertebral “romanus” lesions ın ankylosing spondylitis
demonstrated by contrast enhanced gd-dtpa magnetic
resonance ımaging. Skeletal Radiol 2000;29:27-33. doi:
10.1007/s002.560.050005
- [8] Ward R, Caruthers S, Yablon C, Blake M, DiMasi M, Eustace S.
Analysis of diffusion changes ın posttraumatic bone marrow
using navigator-corrected diffusion gradients. AJR Am J
Roentgenol 2000;174:731-4. doi: 10.2214/ajr.174.3.1740731
- [9] Navallas M, Ares J, Beltrán B, Lisbona MP, Maymó J, Solano
A. Sacroiliitis associated with axial spondyloarthropathy: new
concepts and latest trends. Radiographics 2013;33:933–56.
doi: 10.1148/rg.334125025
- [10] Catan Rudwaleit M, Haibel H, Baraliakos X, et al. The early
disease stage ın axial spondylarthritis: results from the
German spondyloarthritis inception cohort. Arthritis Rheum
2009 Mar;60:717-27. doi: 10.1002/art.24483. doi: 10.1002/
art.24483.
- [11] Catan L, Boariu M, Amaricai E, et al. Predicting functional
disability in patients with spondyloarthritis using a crpbased
algorithm: a 3-year prospective study. Exp Ther Med
2021;21:89. doi:10.3892/etm.2020.9521.Epub 2020 Nov 26.
- [12] Braun J, Bollow M, Eggens U, König H, Distler A, Sieper
J. Use of dynamic magnetic resonance ımaging with fast
ımaging ın detection of early and advanced sacroiliitis
ın spondylarthropathy patients. Arthritis Rheumatol
1994;37:1039-45 doi: 10.1002/ art. 178.037.0709
- [13] Braun J, Bollow M, Sieper J. Radiologic diagnosis and patology
of the spondyloarthropathies. Rheum Dis Clin North Am
1998;24:697-735. doi: 10.1016/s0889-857x(05)70038-7
- [14] Van den Berg R, Lenczner G, Feydy A, et al. Agreement
between clinical practice and trained central reading in
reading of sacroiliac joints on plain pelvic radiographs. Results
from the DESIR cohort. Arthritis Rheumatol 2014; 66:2403-
11. doi: 10.1002/art.38738
- [15] Baraliakos X, Landewe R, Braun J. Magnetic resonance
imaging in ankylosing spondylitis. Future Rheumatol
2006;1:423-31. doi: 10.2217/17460816.1.4.423
- [16] Bredella MA, Steinbach LS, Morgan S, Ward M, Davis JC. MRI
of the sacroiliac joints ın patients with moderate to severe
ankylosing spondylitis. AJR 2006;187:1420-6. doi: 10.2214/
AJR.05.1423
- [17] Jans L, Egund N, Eshed I, Sudol-Szopińska I, Jurik AG.
Sacroiliitis in axial spondyloarthritis: assessing morphology
and activity. Semin Musculoskelet Radiol 2018;22:180-8.
doi:10.1055/s-0038.163.9470
- [18] Muche B, Bollow M, Francois RJ, Seiper J, Hamm B, Braun
J. Anatomic structures ın early – and late – stage sacroiliitisin spondyloarthritis.
Arthritis Rheum 2003;48:1374-84. doi:10.1002/art.10934
- [19] Otveen J, Prevo R, den Boer J, van de Laar M. Early detection
of sacroiliitis on magnetic resonance imaging and subsequent
development of sacroiliitis on plain radiography. A prospective,
longitudinal study. J Rheumatol 1999;26:1953-8.
- [20] Althoff CE, Feist E, Burova E, et al. Magnetic resonance
ımaging of active sacroiliitis: do we really need gadolinium?
Eur J Radiol 2009;71:232-6. doi: 10.1016/j.ejrad.2009.04.034
- [21] Yu W, Feng B, Dion E, Yang H, Jiang M, Genant HK.
Comparison of radiography, computed tomography and
magnetic resonance imaging in the detection of sacroiliitis
accompanying ankylosing spondylitis. Skeletal Radiol 1998;
27:311-20. doi:10.1007/s002.560.050388
- [22] Remy M, Bouillet P, Bertin P, Leblanche AF, Bonnet
C, Pascaud JL. Evaluation of magnetic resonance ımaging fort
the detection of sacroiliitis ın patients with early seronegative
spondyloarthropathy. Rev Rheum Engl Ed 1996; 63: 577-83.
- [23] Gaspersic N, Sersa I, Jevtic V, Tomsic M, Praprotnik S.
Monitoring ankylosing spondylitis therapy by dynamic
contrast-enhanced and diffusion-weighted magnetic
resonance ımaging. Skeletal Radiol 2008;37:123-31. doi:
10.1007/s00256.007.0407-2
- [24] Bollow M, Braun J, Hamm B, et al. Early sacroiliitis in
patients with spondyloarthropathy: evaluation with dynamic
gadolinium-enhanced MR imaging. Radiology 1995;194:529-
36. doi:10.1148/radiology.194.2.7824736
- [25] Sahin N, Hacibeyoglu H, Ince O, et al. Is there a role for DWI
ın the diagnosis of sacroiliitis based on ASAS criteria? Int J
Clin Exp Med 2015;8:7544-52.
- [26] Bozgeyik Z, Özgöcmen S, Kocakoc¸ E. Role of diffusionweighted
MRI in the detection of early active sacroiliitis. Am J
Roentgenol 2008;191:980-6. doi:10.2214/AJR.07.3865
- [27] Gezmis E, Donmez FY, Agildere M. Diagnosis of early
sacroiliitis in seronegative spondyloarthropathies by DWI
and correlation of clinical and laboratory findings with
ADC values. Eur J Radiol 2013;82:2316-21. doi: 10.1016/j.
ejrad.2013.08.032
- [28] Puhakka KB, Jurik AG, Schiottz-Christensen B, et al. Magnetic
resonance ımaging of sacroiliitis in early seronegative
spondylarthropathy. abnormalities correlated to clinical and
laboratory findings. Rheumatology (Oxford) 2004;43:234-7.
doi: 10.1093/rheumatology/keh008